Anthem Biosciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	455,737	368,557	-	-	-	-
Market Cap Growth	5.30%	-	-	-	-	-
Enterprise Value	446,892	359,342	-	-	-	-
Last Close Price	809.20	654.54	-	-	-	-
PE Ratio	80.06	62.28	-	-	-	-
Forward PE	60.22	54.93	-	-	-	-
PS Ratio	22.70	17.31	-	-	-	-
PB Ratio	14.98	12.11	-	-	-	-
P/TBV Ratio	14.98	12.12	-	-	-	-
P/FCF Ratio	71.96	58.20	-	-	-	-
P/OCF Ratio	53.97	43.64	-	-	-	-
PEG Ratio	2.51	2.29	-	-	-	-
EV/Sales Ratio	22.26	16.88	-	-	-	-
EV/EBITDA Ratio	55.24	42.77	-	-	-	-
EV/EBIT Ratio	67.30	50.72	-	-	-	-
EV/FCF Ratio	70.56	56.74	-	-	-	-
Debt / Equity Ratio	0.02	0.02	0.05	0.12	0.07	0.04
Debt / EBITDA Ratio	0.07	0.06	0.17	0.47	0.29	0.10
Debt / FCF Ratio	-	0.09	12.13	-	1.08	0.33
Net Debt / Equity Ratio	-0.29	-0.29	-0.15	-0.21	-0.41	-0.41
Net Debt / EBITDA Ratio	-1.10	-1.05	-0.55	-0.80	-1.63	-0.96
Net Debt / FCF Ratio	-	-1.40	-39.65	2.70	-6.06	-3.12
Asset Turnover	-	0.68	0.71	0.64	0.58	0.94
Inventory Turnover	-	3.68	2.83	3.67	3.81	9.15
Quick Ratio	-	4.70	2.89	3.35	6.78	4.18
Current Ratio	-	5.54	4.56	4.38	8.07	4.83
Return on Equity (ROE)	-	21.71%	20.82%	20.04%	24.88%	39.44%
Return on Assets (ROA)	-	14.20%	14.12%	12.03%	12.81%	24.49%
Return on Invested Capital (ROIC)	22.65%	24.24%	22.71%	25.61%	31.47%	56.74%
Return on Capital Employed (ROCE)	-	22.80%	23.70%	20.60%	20.10%	37.30%
Earnings Yield	1.26%	1.61%	-	-	-	-
FCF Yield	1.39%	1.72%	-	-	-	-
Dividend Yield	0.25%	0.31%	-	-	-	-
Buyback Yield / Dilution	-1.42%	-1.03%	0.96%	0.61%	0.00%	-4.33%
Total Shareholder Return	-1.17%	-0.72%	0.96%	0.61%	-	-4.33%